会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Pillow
    • US11191375B2
    • 2021-12-07
    • US16632864
    • 2019-04-09
    • He Liu
    • He Liu
    • A47G9/10
    • The present application discloses a pillow, the pillow includes a pillow body; a first raised portion disposed on a first side of the pillow body and having a first raised height so as to support a neck of a human body in a supine position; and a second raised portion disposed on a side of the pillow body and having a second raised height so as to support the neck of the human body in a lateral position; wherein the first height is less than the second height. In the present application, the first side of the pillow body is provided with raised portions with different positions, which can meet the different requirements of heights of the pillow of human body in different sleeping positions, the structure is simple, and is helpful for human head to relax and improve sleep quality.
    • 4. 发明授权
    • Uncontrolled spatial multiple access in wireless networks
    • 无线网络中不受控制的空间多址接入
    • US08340062B2
    • 2012-12-25
    • US12792677
    • 2010-06-02
    • Kun TanJiansong ZhangYongguang ZhangHe LiuJi Fang
    • Kun TanJiansong ZhangYongguang ZhangHe LiuJi Fang
    • H04L27/28
    • H04L1/0045H04L1/208H04L25/03891
    • An uncontrolled spatial multiple access system and method facilitating spatial multiple access for multiple devices in a wireless local-area network (WLAN). Embodiments of the system and method increase throughput of the wireless network by facilitating concurrent encoded frame transmission. Decoding of the quasi-overlapped frames is achieved using a chain decoding technique that takes data streams (or signals) containing the quasi-overlapping encoded frames and isolates each encoded frame so that the frame can be decoded. Quasi-overlapped frames means that the frames are overlapped in the body of the frame but not at the preamble (or headers) of the frames. Embodiments of the chain decoding also use interference nullifying and interference cancellation to enable concurrent quasi-overlapping transmission. A carrier counting multiple access technique of embodiments of the system and method allow wireless networks to retain their asynchronous nature while supporting spatial multiple access and maintain backwards compatibility with the IEEE 802.11 standard.
    • 一种不受控制的空间多址系统和方法,其促进无线局域网(WLAN)中的多个设备的空间多址接入。 该系统和方法的实施例通过促进并发编码的帧传输来增加无线网络的吞吐量。 使用链式解码技术来实现准重叠帧的解码,链路解码技术获取包含准重叠编码帧的数据流(或信号),并隔离每个编码帧,使得帧可以被解码。 准重叠帧意味着帧在帧的主体中重叠,但不在帧的前导码(或报头)处。 链路解码的实施例还使用干扰无效和干扰消除来实现并行准重叠传输。 计算系统和方法的实施例的多址接入技术的载波允许无线网络保持其异步性质,同时支持空间多址并保持与IEEE 802.11标准的向后兼容性。
    • 5. 发明申请
    • UNCONTROLLED SPATIAL MULTIPLE ACCESS IN WIRELESS NETWORKS
    • 无线网络中的无限空间多路访问
    • US20110299612A1
    • 2011-12-08
    • US12792677
    • 2010-06-02
    • Kun TanJiansong ZhangYongguang ZhangHe LiuJi Fang
    • Kun TanJiansong ZhangYongguang ZhangHe LiuJi Fang
    • H04L27/28
    • H04L1/0045H04L1/208H04L25/03891
    • An uncontrolled spatial multiple access system and method facilitating spatial multiple access for multiple devices in a wireless local-area network (WLAN). Embodiments of the system and method increase throughput of the wireless network by facilitating concurrent encoded frame transmission. Decoding of the quasi-overlapped frames is achieved using a chain decoding technique that takes data streams (or signals) containing the quasi-overlapping encoded frames and isolates each encoded frame so that the frame can be decoded. Quasi-overlapped frames means that the frames are overlapped in the body of the frame but not at the preamble (or headers) of the frames. Embodiments of the chain decoding also use interference nullifying and interference cancelation to enable concurrent quasi-overlapping transmission. A carrier counting multiple access technique of embodiments of the system and method allow wireless networks to retain their asynchronous nature while supporting spatial multiple access and maintain backwards compatibility with the IEEE 802.11 standard.
    • 一种不受控制的空间多址系统和方法,其促进无线局域网(WLAN)中的多个设备的空间多址接入。 该系统和方法的实施例通过促进并发编码的帧传输来提高无线网络的吞吐量。 使用链式解码技术来实现准重叠帧的解码,链路解码技术获取包含准重叠编码帧的数据流(或信号),并隔离每个编码帧,使得帧可以被解码。 准重叠帧意味着帧在帧的主体中重叠,但不在帧的前导码(或报头)处。 链路解码的实施例还使用干扰无效和干扰消除来实现并行准重叠传输。 计算系统和方法的实施例的多址接入技术的载波允许无线网络保持其异步性质,同时支持空间多址并保持与IEEE 802.11标准的向后兼容性。
    • 6. 发明授权
    • Preparation and use of nucleated red blood cell simulating particles and hematology control mixtures
    • 有核红细胞模拟颗粒和血液控制混合物的制备和使用
    • US08647877B2
    • 2014-02-11
    • US12975053
    • 2010-12-21
    • Cheng DengZuyue XuHe Liu
    • Cheng DengZuyue XuHe Liu
    • G01N31/00A01N1/02
    • G01N33/5094G01N21/6428G01N33/80G01N33/96G01N2800/22Y10T436/101666
    • The present disclosure provides a nucleated red blood cell simulating particle, which may be leukocytes bound to a fluorescent-staining inhibitor capable of stably binding to the nucleus or a nucleic acid in a cell so as to reduce the binding capacity of the particles to a fluorescent dye during their detection. The present disclosure also provides a method for preparing nucleated red blood cell simulating particles, including the following steps: (a) obtaining purified leukocytes; (b) suspending the leukocytes in a cell treatment solution containing a fluorescent-staining inhibitor which stably binds to the nucleus or a nucleic acid in a cell, and (c) washing the obtained product. The present disclosure also provides a hematology control mixture containing the nucleated red blood cell simulating particles. In addition, the present disclosure describes the use of the nucleated red blood cell simulating particles and the hematology control mixtures comprising the same, for the quality control of a blood cell analyzer.
    • 本公开提供了模拟粒子的有核红细胞,其可以是与能够稳定地结合细胞核的荧光染色抑制剂或细胞中的核酸结合的白细胞,以降低颗粒与荧光的结合能力 染料在检测期间。 本发明还提供了一种制备有模红细胞模拟颗粒的方法,包括以下步骤:(a)获得纯化的白细胞; (b)将白细胞悬浮于含有稳定结合细胞核的荧光染色抑制剂的细胞处理溶液或细胞中的核酸上,(c)洗涤所得产物。 本公开还提供了含有模拟红细胞模拟颗粒的血液控制混合物。 此外,本公开内容描述了用于血细胞分析仪的质量控制的模拟有核红细胞模拟颗粒的使用和包含其的血液控制混合物的用途。
    • 7. 发明申请
    • System and Method for Re-home Sequencing Optimization
    • 用于重新排序优化的系统和方法
    • US20100017247A1
    • 2010-01-21
    • US12443956
    • 2007-03-30
    • Feng LiuDongdong LiWill A. EgnerChen LiaoYindong ZhengHe Liu
    • Feng LiuDongdong LiWill A. EgnerChen LiaoYindong ZhengHe Liu
    • G06Q10/00G06Q50/00
    • H04W16/18G06Q10/0633H04L41/12H04L41/145H04Q2213/13098H04W16/22H04W24/02
    • A system and method for rehome sequencing optimization of a telecommunications network. In a preferred embodiment, a practicable optimized rehome sequencing plan is determined for a rehome plan in order to migrate the network topology from an initial state to a final state while minimizing the costs incurred during the network state transitions across multiple time periods. Constraints that may be considered include specific market restrictions such as the limit on the number of network elements in a cluster, the limit on the number of clusters in a sequencing step, the limit on the number of sequencing steps, and the immobility limit on the network elements. Constraints also may include cost restrictions incurred during network transitions, such as individual cost limits during each network transition state and an overall cost limit of network transitions from the initial state to the final state.
    • 一种用于电信网络重新测序优化的系统和方法。 在优选实施例中,针对重新设计方案确定可行的优化的重新排序顺序计划,以便将网络拓扑从初始状态迁移到最终状态,同时最小化在多个时间段内的网络状态转换期间产生的成本。 可以考虑的约束包括具体的市场限制,例如集群中网络元素数量的限制,排序步骤中的集群数量限制,排序步骤数量的限制以及排序步骤的不动点限制 网络元素。 限制也可能包括在网络转换过程中产生的成本限制,例如每个网络过渡状态期间的单个成本限制以及从初始状态到最终状态的网络转换的总体成本限制。
    • 9. 发明授权
    • Acyclic nucleoside phosphonate derivatives and medical uses thereof
    • 非环型核苷膦酸衍生物及其医疗用途
    • US09187507B2
    • 2015-11-17
    • US13514749
    • 2010-06-21
    • Bohua ZhongXinhua HeYongguang WangHe Liu
    • Bohua ZhongXinhua HeYongguang WangHe Liu
    • C07F9/6561A61K31/683
    • C07F9/65616
    • The present invention relates to an acyclic nucleoside phosphonate derivative and medical uses thereof. Specifically, the present invention relates to an acyclic nucleoside phosphonate derivative of Formula I having strong potency against viruses, such as hepatitis B virus, and low cytotoxicity, or a pharmaceutically acceptable salt, isomer, hydrate or solvate thereof, wherein R1 is H or methyl; each R2 is independently —R3 or —OR3, each R3 is independently C1-C8 alkyl, C3-C8 cycloalkyl. The present invention further relates to a process for preparing the compounds of Formula I, a pharmaceutical composition comprising the compound, and the medical uses of the compound. The acyclic nucleoside phosphonate derivative of the present invention has activity against virus such as hepatitis B virus and good in vivo behavioral traits.
    • 本发明涉及无环核苷膦酸衍生物及其医疗用途。 具体地说,本发明涉及对乙型肝炎病毒等病毒具有强效力和低细胞毒性的式I的无环核苷膦酸酯衍生物或其药学上可接受的盐,异构体,水合物或溶剂化物,其中R1是H或甲基 ; 每个R 2独立地是-R 3或-OR 3,每个R 3独立地是C 1 -C 8烷基,C 3 -C 8环烷基。 本发明还涉及制备式I化合物的方法,包含该化合物的药物组合物和该化合物的医学用途。 本发明的无环核苷膦酸酯衍生物具有抗乙型病毒等病毒的活性和体内行为特性良好的活性。